China Drugmaker Access May Require Profit Cut, Chen Says

Western drugmakers may have to give hefty subsidies and forgo some profit on expensive cancer drugs if they want access to China’s “huge market,” the country’s former health minister said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.